A detailed history of Td Waterhouse Canada Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 314 shares of HAE stock, worth $23,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314
Previous 364 13.74%
Holding current value
$23,075
Previous $27.8 Million 44.85%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$47.67 - $78.17 $2,383 - $3,908
-50 Reduced 13.74%
314 $15.3 Million
Q2 2025

Aug 11, 2025

BUY
$56.04 - $74.77 $2,802 - $3,738
50 Added 15.92%
364 $27.8 Million
Q4 2024

Feb 13, 2025

BUY
$71.16 - $93.38 $22,344 - $29,321
314 New
314 $24.5 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.